O’Connell, Susan
Dale, Megan
Morgan, Helen
Dillon, Bernice
Cleves, Andrew http://orcid.org/0000-0003-0431-3138
Morris, Rhys
Carolan-Rees, Grace
Funding for this research was provided by:
National Institute for Health and Care Excellence (External Assessment Centre contract)
Article History
Accepted: 21 October 2021
First Online: 16 November 2021
Declarations
:
: SO, MD, HM, AC, RM, BD and GC-R contributed to the preparation of this manuscript. GC-R reviewed the full assessment report as well as this article. RM reviewed the article and can act as a guarantor for the overall content.
: Susan O’Connell, Megan Dale, Andrew Cleves and Rhys Morris and are employees of the NHS and Grace Carolan-Rees was an employee of the NHS until September 2020, which has a financial interest in the guidance on which this project is based. Helen Morgan is a Cardiff University employee and has no conflicts of interest to declare. Bernice Dillon is a NICE employee and had no role in the production of the assessment report but contributed to the preparation of this manuscript. This summary of the Medical Technology Guidance was produced following the publication of the final guidance report. The article has not been externally peer reviewed by Applied Health Economics and Health Policy, but has been reviewed externally by NICE. Cedar was funded by the NICE Medical Technologies Evaluation Programme for its work.